Clinical Trial Update: Tobramycin in Bronchiectasis Colonized With Pseudmonas Aeruginosa [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating tobramycin for bronchiectasis patients colonized with Pseudomonas aeruginosa is underway, with status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis
• Pseudomonas Infections

Drugs mentioned

• TOBRAMYCIN (Tobramycin)

Snippet

Sponsor: Guangzhou Institute of Respiratory Disease | Conditions: Bronchiectasis Adult, Pseudomonas Infections | Phase 3 | Status: UNKNOWN